Osteopontin is a glycoprotein expressed in both cardiomyocytes and fibroblasts, upregulated in individuals with heart failure, and may thus represent a new biomarker that facilitates risk stratification in patients with heart failure [48]. Here, SPP1 is linked to heart failure.